Drug combination treats brain cancer.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000821:virology*; D018791:CD4 Lymphocyte Count; D004359:Drug Therapy, Combination; D020031:Epstein-Barr Virus Infections / Q000150:complications; D015774:Ganciclovir / Q000627:therapeutic use*; D015658:HIV Infections / Q000097:blood / Q000150:complications* / Q000276:immunology; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy* / Q000821:virology*; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome; D015215:Zidovudine / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D007376:Interleukin-2; D015215:Zidovudine; D015774:Ganciclovir